-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Symbol 6T4-
Trevena IncBörse Börse MünchenSymbol 6T4
-
TREVENA INCBörse Quotrix System der Börse DüsseldorfSymbol 6T4
-
TREVENA INCBörse Börse DüsseldorfSymbol 6T4
-
TREVENA INCBörse Tradegate System der Deutsche Börse AG (60%)Symbol 6T4
-
TREVENA INCBörse Börse StuttgartSymbol 6T4
-
TREVENA INCBörse Gettex System der Börse MünchenSymbol 6T4
-
ISIN US89532E1091 WKN: A1XDSLSymbol TRVN
-
ISIN US89532E1091
-
Symbol 6T4
-
Symbol 6T4
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
363.524.448 oder 253.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
24 oder 43 Mitarbeiter
Trevena Inc underperformed den DAX um -125 % vom 16.05.2014 bis 16.07.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 1,55 EUR -3,18%
Dir gefallen die Informationen zu Trevena Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Trevena Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Trevena Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Trevena Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
26 News & Informationen zur Trevena Inc Aktie
Trevena Announces Two OLINVYK® Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY® 2021
CHESTERBROOK, Penn., Aug. 30, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and…
Trevena Announces Two OLINVYK® Abstracts Highlighting Safety Data Accepted At ANESTHESIOLOGY® 2021
CHESTERBROOK, Penn., Aug. 30, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and
Trevena Announces Wake Forest Baptist Health Joining OLINVYK® Clinical Outcomes Study
— Study is being led by Cleveland Clinic; designed to evaluate potential benefit of OLINVYK on respiratory, GI, and cognitive function outcomes in…
Stocks That Hit 52-Week Lows On Monday
Before 10 a.m. ET on Monday, 29 stocks hit new 52-week lows.
Significant Points: The largest company by market cap to set a new 52-week low …
Trevena Stock: Remaining Patient After A Disappointing Q2 Earnings (NASDAQ:TRVN)
Trevena recently reported disappointing Q2 earnings. I discuss why I am remaining patient with my TRVN and how I intend to manage this position
Trevena, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:TRVN)
The following slide deck was published by Trevena, Inc.
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
Trevena (TRVN) Reports Q2 Loss, Misses Revenue Estimates
Trevena (TRVN) delivered earnings and revenue surprises of -12.50% and -85.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Trevena EPS misses by $0.02, misses on revenue (NASDAQ:TRVN)
Trevena (TRVN): Q2 GAAP EPS of -$0.09 misses by $0.02.Revenue of $0.18M misses by $0.95M.Cash and cash equivalents were $91.0 million as of June 30, 2021, which the Company believes will…
Trevena Reports Second Quarter 2021 Results
Company reaffirms YE goal of 100 formulary wins OLINVYK respiratory physiology study currently enrolling, topline data expected by YE 2021 NIH /…
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
• ITeos …
Trevena Announces Publication Highlighting Risk / Benefit Analysis of OLINVYK® in Pain and Therapy
Exploratory analysis shows OLINVYK treated patients are ~50% less likely to experience an AE compared to morphine patients at equivalent levels of…
Trevena Announces Publication Highlighting Risk / Benefit Analysis Of OLINVYK® In Pain And Therapy
CHESTERBROOK, Pa., Aug. 10, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization
Oncorus : ? Former Merck executive brings extensive experience in corporate development, licensing and financial evaluation, and expertise advising clinical stage public biopharmaceutical companies ?
– Former Merck executive brings extensive experience in corporate development, licensing and
financial evaluation, and expertise advising clinical stage public… | July 29, 2021
Oncorus Expands its Board with Appointment of Barbara Yanni
— Former Merck executive brings extensive experience in corporate development, licensing and financial evaluation, and expertise advising clinical stage…
Trevena Enrolls First Patient For ACTIV-4 Host Tissue Study Of Its Covid Drug
(RTTNews) – Trevena, Inc. (TRVN) on Monday said first patient has been enrolled in the ACTIV-4 Host Tissue study of the company's investigational …
Trevena Announces First Patient Enrolled In NIH-Funded ACTIV-4 Host Tissue Trial Of TRV027 For COVID-19
CHESTERBROOK, Pa., July 26, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization
Trevena Announces First Patient Enrolled in NIH-Funded ACTIV-4 Host Tissue Trial of TRV027 for COVID-19
TRV027 will be dosed in ~300 patients in nationwide trial led by Vanderbilt University Medical Center (VUMC)…
Trevena Announces Publication Of OLINVYK® Health Economic Model In Journal Of Comparative Effectiveness Research
Models demonstrate substantial overall cost savings for hospitals when using OLINVYK compared to IV morphine in postoperative care
CHESTERBROOK, Pa., July
Trevena Announces First Patient Enrolled In OLINVYK® Phase 3 Trial In China In Partnership With Jiangsu Nhwa Pharmaceutical
Nhwa is conducting and funding this study to support NDA regulatory filing in China
Trevena expects to receive approval and commercialization milestones,
Precision Drilling Corp (PDS) Fell Out Of Favor With Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their…
Here is What Hedge Funds Think About Bluegreen Vacations Holding Corporation (BVH)
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors…
(NASDAQ:TRVN)Trevena shares fall after reverse stock split proposal
Trevena (TRVN) shares slide over10%during premarket trading after the company proposed a potential reverse stock split cutting the number of authorized shares by half to 100M.The…
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.90% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.90%
2 Best Reddit Healthcare Stocks to Buy Now
These high-risk, high-reward healthcare stocks have outperformed the market over the past year.
Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK™ and Announces Anticipated Pipeline Catalysts
—
Build-out of customer-facing team on track for this quarter
OLINVYK comprehensive product dossier / health economic model now available to facilitate …